NCT00908388

Evaluation of the GORE Conformable TAG® Thoracic Endoprosthesis for Treatment of Acute Complicated Type B Aortic Dissection

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: W.L.Gore & Associates · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The primary objective of this study is to determine the safety and efficacy of the GORE Conformable TAG Thoracic Endoprosthesis (CTAG) for treatment of subjects with acute complicated type B aortic dissection.

Conditions

• Type B Aortic Dissection

Interventions

Type	Name	Description
DEVICE	GORE TAG® Thoracic Endoprosthesis	Endoprosthetic Implant

Timeline

• Start date: 2009-10-01
• Primary completion: 2012-02-01
• Completion: 2017-02-28
• First posted: 2009-05-25
• Last updated: 2017-10-27
• Results posted: 2014-05-16

Locations

37 sites across 1 country: United States